Interleukin-19 in breast cancer

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Chen, Ying Yin ^a,b   Li, Chien Feng ^a   Yeh, Ching Hua ^c   Chang, Ming Shi ^d   Hsing, Chung Hsi ^a,e  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL FORMOSA UNIVERSITY   (Taiwan)

^c CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 19; BIOLOGICAL MARKER; IL19 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

AUTOCRINE EFFECT; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CYTOKINE PRODUCTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MICROENVIRONMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SQUAMOUS CELL CARCINOMA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL MOTION; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; METASTASIS; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL; TUMOR MICROENVIRONMENT; BREAST TUMOR; PAGET NIPPLE DISEASE;

BIOLOGICAL MARKERS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKINS; NEOPLASM METASTASIS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MICROENVIRONMENT;

EID: 84877949154     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/294320     Document Type: Review

References (65)

1. DeNardo D. G., Coussens L. M., Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Research 2007 9 4 212 2-s2.0-40349094954
2. Rao V. S., Dyer C. E., Jameel J. K., Drew P. J., Greenman J., Potential prognostic and therapeutic roles for cytokines in breast cancer (Review). Oncology Reports 2006 15 1 179 185 2-s2.0-33644874747
3. Lindstrom L. S., Karlsson E., Wilking U. M., Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression. Journal of Clinical Oncology 2012 30 21 2601 2608
4. Yao-Lung K., Dar-Ren C., Tsai-Wang C., Clinicopathological features of triple-negative breast cancer in Taiwanese women. International Journal of Clinical Oncology 2011 15 5 500 505 2-s2.0-79953102565 10.1007/s10147-011-0211-9
5. Pierce B. L., Ballard-Barbash R., Bernstein L., Baumgartner R. N., Neuhouser M. L., Wener M. H., Baumgartner K. B., Gilliland F. D., Sorensen B. E., McTiernan A., Ulrich C. M., Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. Journal of Clinical Oncology 2009 27 21 3437 3444 2-s2.0-70249127607 10.1200/JCO.2008.18. 9068
6. Mantovani A., Marchesi F., Porta C., Sica A., Allavena P., Inflammation and cancer: breast cancer as a prototype. Breast 2007 16 supplement 2 27 33 2-s2.0-35648933886 10.1016/j.breast.2007.07.013 (Pubitemid 350028552)
7. Nicolini A., Carpi A., Rossi G., Cytokines in breast cancer. Cytokine & Growth Factor Reviews 2006 17 5 325 337 (Pubitemid 44572877)
8. Balkwill F., Mantovani A., Inflammation and cancer: back to Virchow? The Lancet 2001 357 9255 539 545 2-s2.0-0035901090 10.1016/S0140-6736(00)04046-0 (Pubitemid 32173595)
9. Coussens L. M., Werb Z., Inflammation and cancer. Nature 2002 420 6917 860 867 2-s2.0-0037180757 10.1038/nature01322 (Pubitemid 36019639)
10. Ben-Baruch A., The multifaceted roles of chemokines in malignancy. Cancer and Metastasis Reviews 2006 25 3 357 371 2-s2.0-33845535091 10.1007/s10555-006-9003-5 (Pubitemid 44922355)
11. Boon T., van den Eynde B., Tumour immunology. Current Opinion in Immunology 2003 15 2 129 130 2-s2.0-0037375525 10.1016/S0952-7915(03)00010-4 (Pubitemid 36287516)
12. Wilson J., Balkwill F., The role of cytokines in the epithelial cancer microenvironment. Seminars in Cancer Biology 2002 12 2 113 120 2-s2.0-0035999153 10.1006/scbi.2001.0419 (Pubitemid 34680740)
13. Hsing C. H., Cheng H. C., Hsu Y. H., Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome. Clinical Cancer Research 2012 18 3 713 725
14. Naugler W. E., Karin M., The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends in Molecular Medicine 2008 14 3 109 119 2-s2.0-40649109728 10.1016/j.molmed.2007.12.007
15. Massague J., TGFbeta in cancer. Cell 2008 134 2 215 230
16. Romagnani P., Lasagni L., Annunziato F., Serio M., Romagnani S., CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends in Immunology 2004 25 4 201 209 2-s2.0-1642274574 10.1016/j.it.2004.02.006 (Pubitemid 38372168)
17. Chavey C., Bibeau F., Gourgou-Bourgade S., Burlinchon S., Boissière F., Laune D., Roques S., Lazennec G., Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Research 2007 9 1, article R15 2-s2.0-34248148710 10.1186/bcr1648 (Pubitemid 350215146)
18. Woo S. U., Bae J. W., Yang J. H., Kim J. H., Nam S. J., Shin Y. K., Overexpression of interleukin-10 in sentinel lymph node with breast cancer. Annals of Surgical Oncology 2007 14 11 3268 3273 2-s2.0-35348828479 10.1245/s10434-007-9532-3 (Pubitemid 47594287)
19. Sullivan N. J., Sasser A. K., Axel A. E., Vesuna F., Raman V., Ramirez N., Oberyszyn T. M., Hall B. M., Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 2009 28 33 2940 2947 2-s2.0-69249221254 10.1038/onc.2009.180
20. Purohit A., Newman S. P., Reed M. J., The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Research 2002 4 2 65 69 2-s2.0-0036130293 10.1186/bcr425 (Pubitemid 34248122)
21. Sabbioni M. E. E., Siegrist H. P., Bacchi M., Bernhard J., Castiglione M., Thürlimann B., Bonnefoi H., Perey L., Herrmann R., Goldhirsch A., Hürny C., Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment. Breast Cancer Research and Treatment 2000 59 3 279 287 2-s2.0-0034093818 10.1023/A:1006379925343 (Pubitemid 30243050)
22. Hsing C. H., Li H. H., Hsu Y. H., Ho C. L., Chuang S. S., Lan K. M., Chang M. S., The distribution of interleukin-19 in healthy and neoplastic tissue. Cytokine 2008 44 2 221 228 2-s2.0-55749090630 10.1016/j.cyto.2008.06.007
23. Commins S., Steinke J. W., Borish L., The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. Journal of Allergy and Clinical Immunology 2008 121 5 1108 1111 2-s2.0-42749087384 10.1016/j.jaci.2008.02.026
24. Gallagher G., Interleukin-19: multiple roles in immune regulation and disease. Cytokine and Growth Factor Reviews 2010 21 5 345 352 2-s2.0-78649734555 10.1016/j.cytogfr.2010.08.005
25. Wolk K., Kunz S., Asadullah K., Sabat R., Cutting edge: immune cells as sources and targets of the IL-10 family members? Journal of Immunology 2002 168 11 5397 5402 2-s2.0-0036604122 (Pubitemid 34556115)
26. Ouyang W., Rutz S., Crellin N. K., Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annual Review of Immunology 2011 29 71 109
27. Fickenscher H., Hör S., Küpers H., Knappe A., Wittmann S., Sticht H., The interleukin-10 family of cytokines. Trends in Immunology 2002 23 2 89 96 2-s2.0-0036475988 10.1016/S1471-4906(01)02149-4 (Pubitemid 34310150)
28. Dumoutier L., Leemans C., Lejeune D., Kotenko S. V., Renauld J. C., Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. Journal of Immunology 2001 167 7 3545 3549 2-s2.0-0035478639 (Pubitemid 32910793)
29. Zdanov A., Structural features of the interleukin-10 family of cytokines. Current Pharmaceutical Design 2004 10 31 3873 3884 2-s2.0-9944229505 10.2174/1381612043382602 (Pubitemid 39591904)
30. Chang C., Magracheva E., Kozlov S., Fong S., Tobin G., Kotenko S., Wlodawer A., Zdanov A., Crystal structure of interleukin-19 defines a new subfamily of helical cytokines. Journal of Biological Chemistry 2003 278 5 3308 3313 2-s2.0-0037474286 10.1074/jbc.M208602200 (Pubitemid 36801244)
31. Conti P., Kempuraj D., Frydas S., Kandere K., Boucher W., Letourneau R., Madhappan B., Sagimoto K., Christodoulou S., Theoharides T. C., IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26. Immunology Letters 2003 88 3 171 174 2-s2.0-12444340807 10.1016/S0165-2478(03)00087-7 (Pubitemid 36993682)
32. Pestka S., Krause C. D., Sarkar D., Walter M. R., Shi Y., Fisher P. B., Interleukin-10 and related cytokines and receptors. Annual Review of Immunology 2004 22 929 979 2-s2.0-2342659126 10.1146/annurev.immunol.22.012703.104622 (Pubitemid 38680445)
33. Langer J. A., Cutrone E. C., Kotenko S., The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine and Growth Factor Reviews 2004 15 1 33 48 2-s2.0-1642432084 10.1016/j.cytogfr. 2003.10.001 (Pubitemid 38121289)
34. Kotenko S. V., The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine and Growth Factor Reviews 2002 13 3 223 240 2-s2.0-0035992506 10.1016/S1359-6101(02)00012-6 (Pubitemid 34693176)
35. Gallagher G., Dickensheets H., Eskdale J., Izotova L. S., Mirochnitchenko O. V., Peat J. D., Vazquez N., Pestka S., Donnelly R. P., Kotenko S. V., Cloning, expression and initial characterisation of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes and Immunity 2000 1 7 442 450 2-s2.0-0034303102
36. Hsing C. H., Hsieh M. Y., Chen W. Y., Cheung So E., Cheng B. C., Chang M. S., Induction of interleukin-19 and interleukin-22 after cardiac surgery with cardiopulmonary bypass. Annals of Thoracic Surgery 2006 81 6 2196 2201 2-s2.0-33646828508 10.1016/j.athoracsur.2006.01.092 (Pubitemid 43775588)
37. Liao Y. C., Liang W. G., Chen F. W., Hsu J. H., Yang J. J., Chang M. S., IL-19 induces production of IL-6 and TNF- α and results in cell apoptosis through TNF- α Journal of Immunology 2002 169 8 4288 4297 2-s2.0-0037108609
38. Liao S. C., Cheng Y. C., Wang Y. C., Wang C. W., Yang S. M., Yu C. K., Shieh C. C., Cheng K. C., Lee M. F., Chiang S. R., Shieh J. M., Chang M. S., IL-19 induced Th2 cytokines and was up-regulated in asthma patients. Journal of Immunology 2004 173 11 6712 6718 2-s2.0-9144235512
39. Pletnev S., Magracheva E., Kozlov S., Tobin G., Kotenko S. V., Wlodawer A., Zdanov A., Characterization of the recombinant extracellular domains of human interleukin-20 receptors and their complexes with interleukin-19 and interleukin-20. Biochemistry 2003 42 43 12617 12624 2-s2.0-0242381342 10.1021/bi0354583 (Pubitemid 37337552)
40. Preimel D., Sticht H., Molecular modeling of the interleukin-19 receptor complex. Novel aspects of receptor recognition in the interleukin-10 cytokine family. Journal of Molecular Modeling 2004 10 4 290 296 2-s2.0-4544272088 10.1007/s00894-004-0195-8 (Pubitemid 39236651)
41. Parrish-Novak J., Xu W., Brender T., Yao L., Jones C., West J., Brandt C., Jelinek L., Madden K., McKernan P. A., Foster D. C., Jaspers S., Chandrasekher Y. A., Interleukins 19, 20, and 24 signal through two distinct receptor complexes: differences in receptor-ligand interactions mediate unique biological functions. Journal of Biological Chemistry 2002 277 49 47517 47523 2-s2.0-0037033092 10.1074/jbc.M205114200 (Pubitemid 36159270)
42. Menon R., Ismail L., Ismail D., Merialdi M., Lombardi S. J., Fortunato S. J., Human fetal membrane expression of IL-19 and IL-20 and its differential effect on inflammatory cytokine production. Journal of Maternal-Fetal and Neonatal Medicine 2006 19 4 209 214 2-s2.0-33745714801 10.1080/14767050500440986 (Pubitemid 43994944)
43. Azuma Y. T., Matsuo Y., Kuwamura M., Yancopoulos G. D., Valenzuela D. M., Murphy A. J., Nakajima H., Karow M., Takeuchi T., Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflammatory Bowel Diseases 2010 16 6 1017 1028 2-s2.0-77952716486 10.1002/ibd.21151
44. Cuneo A. A., Herrick D., Autieri M. V., Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability. Journal of Molecular and Cellular Cardiology 2010 49 4 647 654 2-s2.0-77956175130 10.1016/j.yjmcc.2010.04.016
45. Yeh C. H., Cheng B. C., Hsu C. C., Induced interleukin-19 contributes to cell-mediated immunosuppression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Annals of Thoracic Surgery 2011 92 4 1252 1259
46. Hsing C. H., Chiu C. J., Chang L. Y., Hsu C. C., Chang M. S., IL-19 is involved in the pathogenesis of endotoxic shock. Shock 2008 29 1 7 15 2-s2.0-37549070678 10.1097/shk.0b013e318067de40
47. Hsing C. H., Hsu C. C., Chen W. Y., Chang L. Y., Hwang J. C., Chang M. S., Expression of IL-19 correlates with Th2 cytokines in uraemic patients. Nephrology Dialysis Transplantation 2007 22 8 2230 2238 2-s2.0-34547839676 10.1093/ndt/gfm179 (Pubitemid 47244701)
48. Li H. H., Lin Y. C., Chen P. J., Hsiao C. H., Lee J. Y. Y., Chen W. C., Tzung T. Y., Wu J. C., Chang M. S., Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. British Journal of Dermatology 2005 153 3 591 595 2-s2.0-24344439870 10.1111/j.1365-2133.2005.06665.x (Pubitemid 41248218)
49. Sakurai N., Kuroiwa T., Ikeuchi H., Hiramatsu N., Maeshima A., Kaneko Y., Hiromura K., Nojima Y., Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. Rheumatology 2008 47 6 815 820 2-s2.0-44849111860 10.1093/rheumatology/ken061 (Pubitemid 351796366)
50. Gabunia K., Ellison S. P., Singh H., Interleukin-19 (IL-19) induces heme oxygenase-1 (HO-1) expression and decreases reactive oxygen species in human vascular smooth muscle cells. Journal of Biological Chemistry 2012 287 4 2477 2484
51. Huang L., Cheng H. C., Isom R., Chen C. S., Levine R. A., Pauli B. U., Protein kinase C ε mediates polymeric fibronectin assembly on the surface of blood-borne rat breast cancer cells to promote pulmonary metastasis. Journal of Biological Chemistry 2008 283 12 7616 7627 2-s2.0-43149096710 10.1074/jbc.M705839200
52. Chaudarya N., Hill R. P., Hypoxia and metastasis in breast cancer. Breast Disease 2006 26 1 55 64 2-s2.0-34247528557 (Pubitemid 46647414)
53. Generali D., Berruti A., Brizzi M. P., Campo L., Bonardi S., Wigfield S., Bersiga A., Allevi G., Milani M., Aguggini S., Gandolfi V., Dogliotti L., Bottini A., Harris A. L., Fox S. B., Hypoxia-inducible factor-1 α expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clinical Cancer Research 2006 12 15 4562 4568 2-s2.0-33748037026 10.1158/1078-0432.CCR-05-2690 (Pubitemid 44297805)
54. Li Y. M., Pan Y., Wei Y., Cheng X., Zhou B. P., Tan M., Zhou X., Xia W., Hortobagyi G. N., Yu D., Hung M. C., Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 2004 6 5 459 469 2-s2.0-7944223780 10.1016/j.ccr.2004.09.027 (Pubitemid 39469982)
55. Paduch R., Walter-Croneck A., Zdzisińska B., Szuster-Ciesielska A., Kandefer-Szerszeń M., Role of reactive oxygen species (ROS), metalloproteinase-2 (MMP-2) and interleukin-6 (IL-6) in direct interactions between tumour cell spheroids and endothelial cell monolayer. Cell Biology International 2005 29 7 497 505 2-s2.0-23744473445 10.1016/j.cellbi.2005.01.007 (Pubitemid 41138211)
56. Johnson R. C., Zhu D., Augustin-Voss H. G., Pauli B. U., Lung endothelial dipeptidyl peptidase IV is an adhesion molecule for lung- metastatic rat breast and prostate carcinoma cells. Journal of Cell Biology 1993 121 6 1423 1432 2-s2.0-0027221739 (Pubitemid 23174557)
57. Stein M., Keshav S., Harris N., Gordon S., Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. Journal of Experimental Medicine 1992 176 1 287 292 2-s2.0-0026762988 10.1084/jem.176.1.287
58. Maglione J. E., Moghanaki D., Young L. J. T., Manner C. K., Ellies L. G., Joseph S. O., Nicholson B., Cardiff R. D., MacLeod C. L., Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Research 2001 61 22 8298 8305 2-s2.0-0035890383 (Pubitemid 33091625)
59. Maeda H., Kuwahara H., Ichimura Y., Ohtsuki M., Kurakata S., Shiraishi A., TGF- β enhances macrophage ability to produce IL-10 in normal and tumor- bearing mice. Journal of Immunology 1995 155 10 4926 4932 2-s2.0-0028972556 (Pubitemid 3010832)
60. Balkwill F., Charles K. A., Mantovani A., Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005 7 3 211 217 2-s2.0-17644394616 10.1016/j.ccr.2005.02.013 (Pubitemid 40568680)
61. Watanabe K., Jose P. J., Rankin S. M., Eotaxin-2 generation is differentially regulated by lipopolysaccharide and IL-4 in monocytes and macrophages. Journal of Immunology 2002 168 4 1911 1918 2-s2.0-0037083509 (Pubitemid 34135793)
62. Bunt S. K., Yang L., Sinha P., Clements V. K., Leips J., Ostrand-Rosenberg S., Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Research 2007 67 20 10019 10026 2-s2.0-35448954376 10.1158/0008-5472.CAN-07-2354 (Pubitemid 47621253)
63. Gallagher G., Eskdale J., Jordan W., Peat J., Campbell J., Boniotto M., Lennon G. P., Dickensheets H., Donnelly R. P., Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses. International Immunopharmacology 2004 4 5 615 626 2-s2.0-2142760057 10.1016/j.intimp.2004.01. 005 (Pubitemid 38553883)
64. Lederer J. A., Rodrick M. L., Mannick J. A., The effects of injury on the adaptive immune response. Shock 1999 11 3 153 159 2-s2.0-0033090250
65. O'Sullivan S. T., Lederer J. A., Horgan A. F., Chin D. H. L., Mannick J. A., Rodrick M. L., Meakins J. L., Baker C. C., Pruitt B. A., Galandiuk S., Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Annals of Surgery 1995 222 4 482 492 2-s2.0-0028857787